Evidence map›Paper›PMID 36851567›Full record

ArticleViruses2023

Rapid System to Detect Variants of SARS-CoV-2 in Nasopharyngeal Swabs.

Marco Favaro, Paola Zampini, Enrico Salvatore Pistoia, Roberta Gaziano, Sandro Grelli, Carla Fontana

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marco FavaroDepartment Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-2184-8054
Paola ZampiniVia Luigi Einaudi, Guidonia Montecelio, 00012 Rome, Italy.
Enrico Salvatore PistoiaDepartment Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Roberta GazianoDepartment Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-1970-2670
Sandro GrelliDepartment Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-1028-3203
Carla FontanaNational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.ORCID 0000-0003-2198-1947
University of Rome Tor Vergata · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITLuigi Einaudi Foundation · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, the reference method for identifying the presence of variants of SARS-CoV-2 is whole genome sequencing. Although it is less expensive than in the past, it is still time-consuming, and interpreting the results is difficult, requiring staff with specific skills who are not always available in diagnostic laboratories. The test presented in this study aimed to detect, using traditional real-time PCR, the presence of the main variants described for the spike protein of the SARS-CoV-2 genome. The primers and probes were designed to detect the main deletions that characterize the different variants. The amplification targets were deletions in the S gene: 25-27, 69-70, 241-243, and 157-158. In the

Indexed as

COVID-19DiffusionDNA PrimersHumansNasopharynxSARS-CoV-2DNA Primersrapid systemSARS-CoV-2variants

Identifiers

PMID36851567
PMCPMC9966895
OpenAlexW4318208195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.